De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma

NCT03822897 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

103

Enrollment

NETWORK

Sponsor class

Conditions

Oropharyngeal Cancer

Interventions

RADIATION: Radiation
DRUG: Cisplatin

Sponsor

Canadian Cancer Trials Group